Eugene Han
NPI: 1164780797
Total Payments
$3,518
2024 Payments
$973.02
Companies
30
Transactions
217
Medicare Patients
2,748
Medicare Billing
$342,067
Payment Breakdown by Category
Food & Beverage$3,442 (97.9%)
Education$55.58 (1.6%)
Other$20.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,442 | 212 | 97.9% |
| Education | $55.58 | 4 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $881.82 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $414.98 | 29 | $0 (2024) |
| Celgene Corporation | $406.57 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $277.65 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $252.32 | 3 | $0 (2023) |
| PFIZER INC. | $191.24 | 12 | $0 (2024) |
| Gilead Sciences, Inc. | $145.18 | 2 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $128.34 | 8 | $0 (2024) |
| GENZYME CORPORATION | $116.34 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $93.69 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $973.02 | 52 | ABBVIE INC. ($342.58) |
| 2023 | $1,133 | 77 | ABBVIE INC. ($249.43) |
| 2022 | $906.11 | 63 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($209.26) |
| 2021 | $302.94 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($73.02) |
| 2020 | $13.64 | 1 | AbbVie Inc. ($13.64) |
| 2019 | $29.52 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($15.00) |
| 2018 | $37.87 | 2 | Gilead Sciences, Inc. ($23.95) |
| 2017 | $121.23 | 1 | Gilead Sciences Inc ($121.23) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Immunology | ||||||
| 10/11/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/12/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 08/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 07/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/25/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $13.62 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 573 | 738 | $461,965 | $70,985 |
| 2022 | 13 | 569 | 710 | $478,914 | $70,762 |
| 2021 | 14 | 679 | 891 | $519,489 | $84,457 |
| 2020 | 15 | 927 | 1,317 | $728,450 | $115,863 |
Total Patients
2,748
Total Services
3,656
Medicare Billing
$342,067
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 125 | 259 | $59,570 | $17,645 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 110 | 115 | $50,370 | $12,624 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 76 | $26,524 | $8,235 | 31.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 34 | 34 | $64,515 | $7,168 | 11.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 76 | 77 | $122,815 | $6,924 | 5.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $79,860 | $5,199 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $15,840 | $5,017 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $12,925 | $3,732 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $10,912 | $2,374 | 21.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $18,634 | $2,067 | 11.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 239 | $54,970 | $14,350 | 26.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 69 | $39,632 | $11,482 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 73 | $25,477 | $7,764 | 30.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $55,028 | $5,847 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 65 | 66 | $105,270 | $5,719 | 5.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $81,675 | $5,208 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $18,040 | $4,795 | 26.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 41 | $17,958 | $4,757 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 42 | $9,870 | $3,412 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,800 | $2,406 | 27.3% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 13 | 14 | $25,410 | $1,836 | 7.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $18,634 | $1,776 | 9.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $18,150 | $1,408 | 7.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 161 | 298 | $70,940 | $18,613 | 26.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 111 | 118 | $43,266 | $13,643 | 31.5% |
About Eugene Han
Eugene Han is a Student in an Organized Health Care Education/Training Program healthcare provider based in Englewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1164780797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eugene Han has received a total of $3,518 in payments from pharmaceutical and medical device companies, with $973.02 received in 2024. These payments were reported across 217 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,442).
As a Medicare-enrolled provider, Han has provided services to 2,748 Medicare beneficiaries, totaling 3,656 services with total Medicare billing of $342,067. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Englewood, NJ
- Active Since 05/02/2012
- Last Updated 09/27/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164780797
Products in Payments
- ZEPOSIA (Drug) $517.04
- RINVOQ (Biological) $347.21
- SKYRIZI (Biological) $239.83
- TRULANCE (Drug) $213.71
- XIFAXAN (Drug) $201.27
- STELARA (Biological) $171.63
- DUPIXENT (Biological) $132.59
- OCALIVA (Drug) $128.34
- Epclusa (Drug) $121.23
- VELSIPITY (Drug) $100.64
- LINZESS (Drug) $85.87
- HUMIRA (Biological) $82.92
- XELJANZ (Drug) $73.60
- DIFICID (Drug) $73.05
- ENTYVIO (Biological) $65.31
- IBSRELA (Drug) $62.75
- TREMFYA (Drug) $55.21
- REMICADE (Biological) $50.81
- INJECTAFER (Drug) $47.65
- HANAROSTENT LowAxTM Colon/Rectum(NNN) (Device) $45.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Englewood
Peter Syre, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $400,851
Student in an Organized Health Care Education/Training Program $400,851
Dr. Nishant Patel, M.d., M.b.a, M.D., M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $18,809
Student in an Organized Health Care Education/Training Program $18,809
Shernett Griffiths
Student in an Organized Health Care Education/Training Program — Payments: $10,532
Student in an Organized Health Care Education/Training Program $10,532
Kimberly Koury, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,326
Student in an Organized Health Care Education/Training Program $5,326
Meghan Kaumaya, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,938
Student in an Organized Health Care Education/Training Program $3,938
Jorge Vivar-Aguirre, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,812
Student in an Organized Health Care Education/Training Program $3,812